An East Asian Study of LDE225

Clinical trial NCT01208831 · COMPLETED

Trial details

NCT number: NCT01208831
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Cancers Medulloblastoma Basal Cell Carcinoma

Start date: 2010-10-01
Primary completion: 2013-10-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.